NCT07207785
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07207785
Title PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma (FIL_PUMA)
Acronym FIL_PUMA
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fondazione Italiana Linfomi - ETS
Indications
Therapies
Age Groups: senior
Covered Countries ITA


No variant requirements are available.